Aspen Aerogels (NYSE:ASPN) PT Raised to $41.00

Aspen Aerogels (NYSE:ASPN) had its price objective boosted by TD Cowen from $36.00 to $41.00 in a research note issued to investors on Tuesday, Benzinga reports. TD Cowen currently has a buy rating on the construction company’s stock.

Several other equities analysts have also recently weighed in on the stock. Barclays began coverage on shares of Aspen Aerogels in a research note on Tuesday, August 6th. They issued an overweight rating and a $27.00 target price for the company. Piper Sandler raised their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an overweight rating in a research report on Wednesday, May 29th. B. Riley upgraded Aspen Aerogels to a strong-buy rating in a report on Tuesday, June 25th. Benchmark reiterated a buy rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, Roth Mkm reaffirmed a buy rating and set a $36.00 price objective (up previously from $28.00) on shares of Aspen Aerogels in a research report on Wednesday, June 12th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus target price of $29.70.

Aspen Aerogels Stock Up 3.1 %

Shares of ASPN opened at $30.14 on Tuesday. The business’s 50 day simple moving average is $24.55 and its 200-day simple moving average is $21.72. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The company has a market capitalization of $2.30 billion, a P/E ratio of -68.50 and a beta of 2.15. Aspen Aerogels has a one year low of $5.32 and a one year high of $33.15.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The business had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. During the same period in the prior year, the business posted ($0.22) earnings per share. Aspen Aerogels’s revenue was up 144.4% compared to the same quarter last year. As a group, sell-side analysts predict that Aspen Aerogels will post 0.12 EPS for the current fiscal year.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 256,944 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the transaction, the chief executive officer now directly owns 502,855 shares of the company’s stock, valued at $14,703,480.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ASPN. Banque Cantonale Vaudoise lifted its holdings in shares of Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in Aspen Aerogels during the second quarter valued at about $84,000. nVerses Capital LLC bought a new stake in Aspen Aerogels in the 2nd quarter worth $95,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels in the second quarter worth $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in shares of Aspen Aerogels in the 2nd quarter valued at approximately $145,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.